tiprankstipranks
Trending News
More News >

AstraZeneca price target raised to $97 from $93 at Berenberg

Berenberg analyst Luisa Hector raised the firm’s price target on AstraZeneca (AZN) to $97 from $93 and keeps a Buy rating on the shares. The firm increased its 2030 revenue forecast by 3% to $79B, ahead of consensus, saying the company has seen “substantial pipeline progress already this year.” AstraZeneca shares should price in a larger pipeline valuation, the analyst tells investors in a research note.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1